How long do antidepressants take to work?

Most antidepressants take 4-6 weeks to reach full effect, though some people notice improvements in sleep and appetite within the first 1-2 weeks. Side effects often appear before benefits, which is why many people quit too early. Give the medication a fair trial of 6-8 weeks before concluding it doesn't work.

Can I stop antidepressants once I feel better?

Don't stop abruptly. Guidelines recommend continuing medication for at least 6-12 months after remission to prevent relapse. For people with recurrent episodes (3+), longer-term or indefinite treatment may be appropriate. Always taper gradually under medical supervision to avoid discontinuation symptoms.

Is therapy or medication better for depression?

Neither is universally better. For mild-to-moderate depression, they perform comparably. For severe depression, combination treatment is most effective. Therapy has lower relapse rates after completion; medication works faster for acute episodes. Your preference matters — treatment you'll actually engage with is the best treatment.

What is treatment-resistant depression?

Treatment-resistant depression is generally defined as failure to respond adequately to at least two different antidepressants given at appropriate doses for adequate duration. It affects about 30% of people with major depression. Options include switching medications, augmentation strategies, TMS, ketamine/esketamine, and clinical trials.

Depression Treatment Options Compared: Therapy, Medication, and Beyond

Depression treatment has more options than ever — and choosing between them can feel overwhelming when you're already depleted. Here's the straightforward comparison: cognitive behavioral therapy (CBT) and SSRI antidepressants are the most proven first-line treatments, each producing response rates around 50-60%. Combining them pushes that to roughly 70%. For treatment-resistant cases, newer options like ketamine, TMS, and psilocybin are showing real promise. The right choice depends on severity, preferences, access, and individual biology.

Psychotherapy

Cognitive Behavioral Therapy (CBT)

CBT is the most studied psychotherapy for depression with the largest evidence base. It focuses on identifying and restructuring negative thought patterns ("I'm worthless," "Nothing will ever improve") and reactivating behaviors that depression has shut down. Typical course: 12-20 weekly sessions. The STAR*D trial and subsequent meta-analyses consistently show CBT performs comparably to medication for mild-to-moderate depression, with a key advantage: lower relapse rates after treatment ends.

Behavioral Activation (BA)

BA strips CBT down to its behavioral component: systematically scheduling activities that provide pleasure or mastery, counteracting the withdrawal cycle that maintains depression. A landmark trial published in The Lancet found BA delivered by junior therapists was as effective as full CBT delivered by senior clinicians. It's simpler, cheaper, and easier to scale — a significant finding for access.

Interpersonal Therapy (IPT)

IPT addresses depression through the lens of relationships — grief, role transitions, conflicts, isolation. It's particularly useful when depression is clearly linked to relational factors and is the strongest evidence-based therapy for postpartum depression.

Medication

SSRIs

Selective serotonin reuptake inhibitors remain the standard first-line medication. Common options: sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac). They take 4-6 weeks to reach full effect. Side effects vary by specific drug but often include nausea initially, sexual dysfunction (30-40% of users), weight changes, and emotional blunting. The Cipriani mega-analysis in The Lancet (2018) compared 21 antidepressants and found all were more effective than placebo, with escitalopram and sertraline offering the best balance of efficacy and tolerability.

SNRIs

Venlafaxine (Effexor) and duloxetine (Cymbalta) add norepinephrine reuptake inhibition. Slightly more effective for severe depression in some analyses, but with more side effects. Duloxetine has the added benefit of FDA approval for chronic pain conditions, making it a good choice when depression and pain coexist.

Bupropion

Works through dopamine and norepinephrine rather than serotonin. Notable for avoiding sexual side effects and weight gain — it can actually aid weight loss. Less effective for depression with prominent anxiety, but a good option when fatigue, low motivation, and concentration problems dominate.

Other Options

MAOIs (phenelzine, tranylcypromine) remain effective for treatment-resistant and atypical depression but require dietary restrictions. Tricyclics are effective but have more side effects and overdose risk. Mirtazapine is useful when insomnia and appetite loss are prominent symptoms.

Combination Treatment

The STAR*D trial — the largest depression treatment study ever conducted — found that after first-line SSRI treatment, about one-third of patients achieved remission. Adding or switching treatments brought cumulative remission to about 67% after four treatment steps. The clear takeaway: if the first thing you try doesn't work, keep going. Most people find something that helps; it sometimes takes persistence.

Combining therapy and medication outperforms either alone, particularly for moderate-to-severe depression. Medication lifts you enough to engage in therapy; therapy teaches skills that prevent relapse after medication stops.

Newer and Emerging Treatments

Ketamine and Esketamine

Ketamine works through glutamate pathways rather than serotonin, and it works fast — often within hours rather than weeks. Esketamine (Spravato), a nasal spray approved by the FDA in 2019, is available for treatment-resistant depression. Effects are rapid but often temporary (days to weeks per session), requiring repeated treatments. It's a genuine breakthrough for acute suicidality and treatment-resistant cases.

Transcranial Magnetic Stimulation (TMS)

TMS uses magnetic pulses to stimulate the left prefrontal cortex. FDA-approved for treatment-resistant depression. Standard protocol: daily 20-40 minute sessions for 4-6 weeks. Response rates are around 50-60% in treatment-resistant populations. Side effects are minimal (headache, scalp discomfort). Newer protocols (Stanford Accelerated Intelligent Neuromodulation Therapy) compress treatment into 5 days with promising results.

Psilocybin

Not yet FDA-approved but in Phase 3 trials. Early results from Imperial College London and Johns Hopkins show large effect sizes for treatment-resistant depression. A single or two-session protocol produces sustained mood improvement in some patients for weeks to months. The mechanism appears to involve increased neural flexibility — essentially breaking rigid patterns of depressive thinking.

Exercise as Treatment

Exercise isn't just a lifestyle suggestion for depression — it has genuine antidepressant effects. A 2023 umbrella meta-analysis in the British Journal of Sports Medicine found exercise produced effects comparable to psychotherapy and medication. Walking or jogging, yoga, and strength training all showed benefits. The dose-response relationship is clear: more is generally better, but even 30 minutes of moderate activity three times weekly produces measurable improvement.

Combining regular physical activity with adequate nutrition creates a foundation that supports all other treatments.

How to Choose

Mild depression: start with therapy (CBT or BA) and lifestyle changes. Moderate depression: therapy plus consider medication. Severe depression: combination treatment from the start. Treatment-resistant: discuss TMS, ketamine/esketamine, or clinical trials with your psychiatrist. Previous response: if a treatment worked before, it's likely to work again.